Ian T Clark

Director

Ian T Clark (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Guardant Health, Inc. (GH). The largest single filing was $7.9M of OLMA (264,800 sh across 3 lots, as filed), executed Dec 19 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$13.9M

shares × price, as filed

Last traded

Aug 4

Filed Aug 5

Median ADV $437.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $14.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

Guardant Health, Inc. GH · 0 buys · 5 sells 5 filings OLMA Olema Pharmaceuticals, Inc. OLMA · 0 buys · 1 sell 1 filing

Recent filings

GHSALE Guardant Health, Inc. View filing → $2.3M
14,180 sh across 2 lots
Exec Aug 4
Filed Aug 5 · 5:05 PM ET GHSALE Guardant Health, Inc. View filing → $735K
6,876 sh × $106.90
Exec May 20
Filed May 22 · 5:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. View filing → $7.9M
264,800 sh across 3 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET GHSALE Guardant Health, Inc. View filing → $3.1M
28,611 sh across 3 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET GHSALE Guardant Health, Inc. View filing → $323K
6,672 sh × $48.38
Exec Jun 17 2025
Filed Jun 20 2025 · 5:30 PM ET GHSALE Guardant Health, Inc. View filing → $213K
7,242 sh × $29.44
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET